Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies

被引：30
|
作者：
Ochoa, Sebastian [1 ]
Ding, Li [1 ]
Kreuzburg, Samantha [1 ]
Treat, Jennifer [2 ]
Holland, Steven M. [1 ]
Zerbe, Christa S. [1 ]
机构：
[1] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, Bethesda, MD 20892 USA
[2] Med Sci & Comp, Rockville, MD USA
来源：
CLINICAL INFECTIOUS DISEASES | 2021年 / 72卷 / 12期
基金：
美国国家卫生研究院;
关键词：
daratumumab; mycobacteria; disseminated; interferon gamma; autoantibodies;
D O I：
10.1093/cid/ciaa1086
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Patients with autoantibodies to interferon-gamma (IFN-gamma) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-gamma who had progressive infection, resulting in clinical and radiographic improvement.
引用
收藏
页码：2206 / 2208
页数：3
相关论文
共 50 条
  • [41] New method for overcoming the interference produced by anti-CD38 monoclonal antibodies in compatibility testing
    Castro Izaguirre, Emma
    del Mar Luis-Hidalgo, Maria
    Larrea Gonzalez, Luis
    Arbona Castano, Cristina
    BLOOD TRANSFUSION, 2020, 18 (04) : 290 - 294
  • [42] Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodies
    Chakraborty, Rajshekhar
    Milani, Paolo
    Palladini, Giovanni
    Gertz, Morie
    LANCET HAEMATOLOGY, 2023, 10 (11): : E936 - E940
  • [43] Anticytokine therapy, especially anti-interferon-γ, as a pathogenetic treatment in Th-1 autoimmune diseases
    Skurkovich, S
    Skurkovich, B
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 684 - 700
  • [44] Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies
    Caroni, Federico
    Sammartano, Vincenzo
    Pacelli, Paola
    Sicuranza, Anna
    Malchiodi, Margherita
    Dragomir, Andreea
    Ciofini, Sara
    Raspadori, Donatella
    Bocchia, Monica
    Gozzetti, Alessandro
    PHARMACEUTICALS, 2025, 18 (02)
  • [45] Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good’s syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report
    Waki Imoto
    Koichi Yamada
    Yuriko Hajika
    Kousuke Okamoto
    Yuka Myodo
    Makoto Niki
    Gaku Kuwabara
    Kazushi Yamairi
    Wataru Shibata
    Naoko Yoshii
    Kiyotaka Nakaie
    Kazutaka Yoshizawa
    Hiroki Namikawa
    Tetsuya Watanabe
    Kazuhisa Asai
    Hiroshi Moro
    Yukihiro Kaneko
    Tomoya Kawaguchi
    Yoshiaki Itoh
    Hiroshi Kakeya
    BMC Infectious Diseases, 20
  • [46] Anti-CD38 monoclonal antibody impairs CD34+mobilization and affects clonogenic potential in multiple myeloma patients
    Zappaterra, Arianna
    Civettini, Ivan
    Cafro, Anna Maria
    Pezzetti, Laura
    Pierini, Silvia
    Anghilieri, Michela
    Bellio, Laura
    Bertazzoni, Paola
    Grillo, Giovanni
    Minga, Periana
    Pioltelli, Maria L.
    Ravano, Emanuele
    Sassone, Marianna
    V. Vigano, Clara
    Volpato, Elisabetta B.
    Gambacorti-Passerini, Carlo
    Rossini, Silvano
    Cairoli, Roberto
    Crocchiolo, Roberto
    BLOOD TRANSFUSION, 2024, 22 (04) : 328 - 337
  • [47] Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy
    Venglar, Ondrej
    Kapustova, Veronika
    Anilkumar Sithara, Anjana
    Zihala, David
    Muronova, Ludmila
    Sevcikova, Tereza
    Vrana, Jan
    Vdovin, Alexander
    Radocha, Jakub
    Krhovska, Petra
    Hrdinka, Matous
    Turjap, Michal
    Popkova, Tereza
    Chyra, Zuzana
    Broskevicova, Lucie
    Simicek, Michal
    Koristek, Zdenek
    Hajek, Roman
    Jelinek, Tomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1439 - 1449
  • [48] CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells
    Wang, Hongjie
    Koob, Theo
    Fromm, Jonathan R.
    Gopal, Ajay
    Carter, Darrick
    Lieber, Andre
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [49] Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma
    Lonial, Sagar
    Bowser, Andrew D.
    Chari, Ajai
    Costello, Caitlin
    Krishnan, Amrita
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11) : 815 - 824
  • [50] Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody
    Seth, Abhishek
    Murray, David
    Buadi, Francis K.
    Gertz, Morie A.
    Yadav, Udit
    Kumar, Shaji K.
    Gonsalves, Wilson I.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (02) : 318 - 321
12345